The Pindolol Tablets, cataloged under National Stock Number 6505-01-173-2073, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Novartis Pharmaceuticals Corporation. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-173-2073 |
| Primary Part Number | NDC00078-0073-05 |
| Item Name | Pindolol Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Novartis Pharmaceuticals Corporation |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 10.000 MILLIGRAMS PINDOLOL ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00378-0127-01 | Mylan Pharmaceuticals Inc (USA) |
| NDC00781-1169-01 | Sandoz Inc. (USA) |
| NDC00172-4218-60 | Zenith Laboratories Inc (USA) |
| NDC00078-0073-05 PRIMARY | Novartis Pharmaceuticals Corporation (USA) |
| Reference | Meaning |
|---|---|
| VISKEN | 5/1 Secondary reference Novartis Pharmaceuticals Corporation |
| NDC00228-2535-10 | 5/9 Secondary reference Actavis Elizabeth Llc Dba Actavis Us Div Actavis Pharma, Inc. |
| VISKEN TABLETS | 5/1 Secondary reference Novartis Pharmaceuticals Corporation |
NSN 6505-01-173-2073 is a Pindolol Tablets, manufactured by Novartis Pharmaceuticals Corporation, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-173-2073 has 4 manufacturer part numbers on file: NDC00378-0127-01 (Mylan Pharmaceuticals Inc), NDC00781-1169-01 (Sandoz Inc.), NDC00172-4218-60 (Zenith Laboratories Inc), NDC00078-0073-05 (Novartis Pharmaceuticals Corporation).
Key specifications for NDC00078-0073-05: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: PINDOLOL TABLETS 10MG 100S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.